Two Lines
The Altai cosmetic company "Two Lines" was founded in 1999 in the science city of Biysk. Work of the company began with release of only two products: agents for excision of warts and papillomas "Superchistotelo" and an agent for restoration of natural hair color "Antisilverin". Today the range of the company contains more than 100 types of production.
The Two Lines company is included into the Altai biopharmaceutical cluster which was framed for support of innovative business in the biopharmaceutical sector. The cluster includes 36 organizations, including "Evalar" and "Altayvitamin".
The Two Lines company is natural cosmetics with scientific approach. Production of the company is result of a successful combination of natural components of Altai and modern technologies. During creation of our production we use natural oils and extracts, mummies, pantohematogen, honey and other natural components which are generously given by the nature of Altai. The correct combination of these components provides exclusivity of structure and allocates production with special characteristics.
The high competitiveness of cosmetic production of the company is confirmed not only with medals and diplomas of prestigious exhibitions, but also constant recognition of consumers long ago. And the modern way of life which closely united to the concepts "health" and "beauty" stimulates experts of "Two lines" on constant creative search with invariable alliance of three components — relevance, quality and efficiency.
Specialists of the Two Lines company are sure that cosmetics of 21 century has to work not only for outer effect as mass cosmetics, but also to make deep internal impact on a skin. Sea-buckthorn, cedar and other most valuable natural oils, birch kidneys, a mummy, pantohematogen, honey, badger fat along with other natural Altai components provide exclusivity of structure and allocate production of the Two Lines company with special characteristics. Developers of the company literally verify combinations of active ingredients for future drugs which as a result steadily prove from year to year the efficiency and sensitivity of influence.